	Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis. PLoS One Arafat HM, Ali A, Tengku Din TADAA, Shamallakh OM, Jusoh R, Yahya MM, Zain WZW, Rahman WFWA. PMID: 42497233 [PubMed - indexed for MEDLINE]
	The health management pathway of breast cancer patients: an exploratory study using patient journey mapping. Psychol Health Med Shen M, Shen Y, Gao Y, Jiang N, Cai L. PMID: 42497118 [PubMed - as supplied by publisher]
	BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis. Breast Cancer Reveneau MF, De Pauw A, Masliah-Planchon J, Decees A, Lakhlifi S, Pasanisi J, Gall JL, Schwartz M, Pagès M, Pierre-Noël E, Sebai M, Caputo SM, Moncoutier V, Tenreiro H, Berthemin C, Carrière J, Dubois d'Enghien C, Abidallah K, Guy C, Fort N, Zaguia N, Taribo AC, Grati OT, Lori L, Maillard A, Benoist C, Frouin E, Merchadou K, Quinquis F, Filser M, Delhomelle H, Le Mentec M, Warcoin M, Bertrand O, Villy MC, Saule C, Mouret-Fourme E, Gauthier-Villars M, Buecher B, Popova T, Stern MH, Renault V, Pasmant E, Stoppa-Lyonnet D, Colas C, Golmard L. PMID: 42496958 [PubMed - as supplied by publisher]
	Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy. J Neurooncol Zhu JW, Fernandes I, Lopes JB, Moravan V, Tran W, Jerzak KJ. PMID: 42496928 [PubMed - indexed for MEDLINE]
	Associations of neighborhood racial and ethnic, economical, and educational segregation with breast cancer risk: The Multiethnic ohort Study. Cancer Causes Control Ihenacho U, Khan-Gates J, Lin K, Abe JV, Inamdar PP, Yang J, Li Y, Sangaramoorthy M, Haiman CA, Le Marchand L, Wilkens LR, Gomez SL, Shariff-Marco S, Wu AH, Cheng I. PMID: 42496782 [PubMed - indexed for MEDLINE]
	SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy. Oncologist Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, Bianchini G, Iwata H, Fasching PA, Nowecki Z, Pascual J, Chen SC, Moreau L, Ruiz-Borrego M, Shai A, Karadurmus N, Jung KH, Kikawa Y, Baird RD, Habash R, Sugarman R, Fox S, Selvi Miralles M, Bartlett CH, Turner N. PMID: 42496653 [PubMed - as supplied by publisher]
	Epigenetic Mechanisms of Breast and Ovarian Cancer Development: Interplay Between DNA Methylation/Demethylation Enzymes, MicroRNAs, and Long Non-Coding RNAs. Epigenomes Lukina SS, Pronina IV, Bril AA, Burdennyy AM, Loginov VI, Morozov SG. PMID: 42496533 [PubMed]
	Exercise-Induced Circulating Lactate Responses in Breast Cancer Survivors: A Systematic Review and Exploratory Meta-Analysis. Muscles Ahmadi Hekmatikar AH, Santamaría G, Celorrio San Miguel AM, Roche E, Khodadadi F, López-Llorente Á, Fernández-Lázaro D. PMID: 42496378 [PubMed]
	Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment. Radiol Imaging Cancer Le NN, Li W, Wilmes LJ, Onishi N, Gibbs JE, Hathi D, Metanat P, Joe BN, Kornak J, Malyarenko D, Chenevert TL, Bolan P, Partridge SC, Hylton NM. PMID: 42496228 [PubMed - indexed for MEDLINE]
	Inavolisib: a second-generation PI3KÎ± inhibitor in HR+/HER2-negative breast cancer. Expert Opin Drug Metab Toxicol Abdy E, Betancourt JP, Kar S. PMID: 42496151 [PubMed - as supplied by publisher]
	Efficient high-risk human papillomavirus screening through pooled testing: a simulation study based on real-world data in low- and middle-income countries. J Glob Health Pan F, Greuter MJ, Koot JA, Cubie H, Nazrul N, Nakisige C, Beltman J, de Bock GH, van der Schans J. PMID: 42495948 [PubMed - indexed for MEDLINE]
	Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study. J Obstet Gynaecol Wei Y, Gong Y, Gong J, Zeng H, Zhong Z, Xiong Y, Li X. PMID: 42495930 [PubMed - indexed for MEDLINE]
	Tumor Profiling Using an NGS Cancer Hotspot Panel in Ukrainian Breast Cancer Patients: Initial Findings of Mutation Frequencies and Clinicopathologic Characteristics. Cancer Control Gulkovskyi R, Fishchuk L, Rossokha Z, Gerashchenko G, Bezverkhiy A, Kashuba V, Lobanova O, Cheshuk V, Vereshchako R, Vershyhora V, Popova O, Gorovenko N, Tkachuk Z, Tukalo M. PMID: 42495879 [PubMed - indexed for MEDLINE]
	Navigating realities: Client and provider perspectives on cervical cancer screening services in rural Uganda: A convergent mixed-methods study. Womens Health (Lond) Kibonire RA, Mphuthi DD, Twinomujuni M, Tumusiime A. PMID: 42495871 [PubMed - indexed for MEDLINE]
	Multidimensional molecular mechanisms of drugÂ resistance in breast cancer: Implications for clinical decisionâ€‘making and treatment strategies (Review). Oncol Rep Xu W, Kang S, Xin S, Wu Y, Zhao Y, Sheng M. PMID: 42495778 [PubMed - indexed for MEDLINE]
	[Corrigendum] Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol Pilco-Ferreto N, Calaf GM. PMID: 42495770 [PubMed - in process]
	The relationship between sarcopenia and breast cancer: mechanistic pathways and clinical relevance. Front Cell Dev Biol Wu Y, Cao H, Li M, Hong J, Zhou H, Gao X, Song D. PMID: 42495721 [PubMed]
	NUPR1 in breast cancer: mechanisms and potential applications. Front Physiol Xiang B, Liu T, Xu D, Wang W. PMID: 42495706 [PubMed]
	Immunological mechanisms of low-grade systemic inflammation and its role in endometrial dysfunction in women with polycystic ovary syndrome. Front Immunol Qu L, Li L, Yang L, Liu Y. PMID: 42495654 [PubMed - indexed for MEDLINE]
	A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer. Front Immunol Lan J, Sun X, Huang X, Zhao Y, Bi Z, Huang W, Luo T, Jing J, Wu X, Liu L. PMID: 42495649 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 332652

Page 1 of 16633



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy